PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Wellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.\', \'Diabetes in Pregnancy Team, Cambridge University Hospitals, Cambridge, UK.\', \'Department of Clinical Biochemistry, Cambridge University Hospitals, Addenbrookes\'s Hospital, Cambridge, UK.\', \'Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.\', \'Department of Population and Clinical Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.\', \'Maternal and Fetal Health Research Centre, University of Manchester, St Mary\'s Hospital, Manchester, UK.\', \'Centre for Cardiovascular Science, Queen\'s Medical Research Institute, Edinburgh, UK.\', \'School of Medicine, Western Sydney University, Campbelltown, NSW, Australia.\', \'Departments of Medicine and Obstetrics and Gynaecology, University of Calgary, Calgary, Canada.\', \'Regional Centre for Endocrinology and Diabetes, Belfast, UK.\', \'Norwich Medical School, Bob Champion Research and Education Building, University of East Anglia, Norwich, UK.\', \'Division of Women\'s Health, Kings College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/dme.14380
?:doi
?:hasPublicationType
?:journal
  • Diabetic medicine : a journal of the British Diabetic Association
is ?:pmid of
?:pmid
?:pmid
  • 32750184
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all